Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.
Fernandez N, Hayes P, Makinde J, Hare J, King D, Xu R, Rehawi O, Mezzell AT, Kato L, Mugaba S, Serwanga J, Chemweno J, Nduati E, Price MA, Osier F, Ochsenbauer C, Yue L, Hunter E, Gilmour J; IAVI protocol C investigators.
Fernandez N, et al. Among authors: mezzell at.
Front Immunol. 2022 Dec 1;13:1029029. doi: 10.3389/fimmu.2022.1029029. eCollection 2022.
Front Immunol. 2022.
PMID: 36532063
Free PMC article.